Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elizabeth C Verna

Showing results (131-140 of 222) with videos related to

Pageof 23
Sort By:
Epidemiology (Cambridge, Mass.)|January 31, 2023
Effectiveness of Remdesivir Treatment Protocols Among Patients Hospitalized with COVID-19: A Target Trial EmulationAlexander Breskin, Catherine Wiener, Adaora A Adimora, et al.
Antimicrobial Agents and Chemotherapy|April 10, 2019
<i>Escherichia coli</i> Harboring <i>mcr-1</i> in a Cluster of Liver Transplant Recipients: Detection through Active Surveillance and Whole-Genome SequencingNenad Macesic, Sabrina Khan, Marla J Giddins, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 30, 2010
Pancreatic cancer screening in a prospective cohort of high-risk patients: a comprehensive strategy of imaging and geneticsElizabeth C Verna, Caroline Hwang, Peter D Stevens, et al.
Hepatology (Baltimore, Md.)|May 4, 2011
Hepatitis C virus-infected women have a higher risk of advanced fibrosis and graft loss after liver transplantation than menJennifer C Lai, Elizabeth C Verna, Robert S Brown, et al.
Journal of Hepatology|December 13, 2021
TAZ-induced Cybb contributes to liver tumor formation in non-alcoholic steatohepatitisXiaobo Wang, Sharon Zeldin, Hongxue Shi, et al.
Clinical Transplantation|March 9, 2023
Living donor liver transplantation: A multi-disciplinary collaboration towards growth, consensus, and a change in cultureAnnMarie Liapakis, Michelle T Jesse, Anjana Pillai, et al.
The New England Journal of Medicine|December 14, 2016
Perioperative Ledipasvir-Sofosbuvir for HCV in Liver-Transplant RecipientsJosh Levitsky, Elizabeth C Verna, Jacqueline G O'Leary, et al.
Journal of Hepatology|May 8, 2014
A US multicenter study of hepatitis C treatment of liver transplant recipients with protease-inhibitor triple therapyJames R Burton, Jacqueline G O'Leary, Elizabeth C Verna, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|October 23, 2023
Outcomes of early vs late treatment initiation in solid organ transplantation from hepatitis C virus nucleic acid test-positive donors to hepatitis C virus-uninfected recipients: Results from the HCV-TARGET studyWesam Aleyadeh, Elizabeth C Verna, Hany Elbeshbeshy, et al.
Transplantation|February 26, 2015
Telaprevir- and Boceprevir-based Triple Therapy for Hepatitis C in Liver Transplant Recipients With Advanced Recurrent Disease: A Multicenter StudyElizabeth C Verna, Varun Saxena, James R Burton, et al.
Pageof 23

Showing results (131-140 of 222) with videos related to

Sort By:
Pageof 23
Epidemiology (Cambridge, Mass.)|January 31, 2023
Effectiveness of Remdesivir Treatment Protocols Among Patients Hospitalized with COVID-19: A Target Trial EmulationAlexander Breskin, Catherine Wiener, Adaora A Adimora, et al.
Antimicrobial Agents and Chemotherapy|April 10, 2019
<i>Escherichia coli</i> Harboring <i>mcr-1</i> in a Cluster of Liver Transplant Recipients: Detection through Active Surveillance and Whole-Genome SequencingNenad Macesic, Sabrina Khan, Marla J Giddins, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 30, 2010
Pancreatic cancer screening in a prospective cohort of high-risk patients: a comprehensive strategy of imaging and geneticsElizabeth C Verna, Caroline Hwang, Peter D Stevens, et al.
Hepatology (Baltimore, Md.)|May 4, 2011
Hepatitis C virus-infected women have a higher risk of advanced fibrosis and graft loss after liver transplantation than menJennifer C Lai, Elizabeth C Verna, Robert S Brown, et al.
Journal of Hepatology|December 13, 2021
TAZ-induced Cybb contributes to liver tumor formation in non-alcoholic steatohepatitisXiaobo Wang, Sharon Zeldin, Hongxue Shi, et al.
Clinical Transplantation|March 9, 2023
Living donor liver transplantation: A multi-disciplinary collaboration towards growth, consensus, and a change in cultureAnnMarie Liapakis, Michelle T Jesse, Anjana Pillai, et al.
The New England Journal of Medicine|December 14, 2016
Perioperative Ledipasvir-Sofosbuvir for HCV in Liver-Transplant RecipientsJosh Levitsky, Elizabeth C Verna, Jacqueline G O'Leary, et al.
Journal of Hepatology|May 8, 2014
A US multicenter study of hepatitis C treatment of liver transplant recipients with protease-inhibitor triple therapyJames R Burton, Jacqueline G O'Leary, Elizabeth C Verna, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|October 23, 2023
Outcomes of early vs late treatment initiation in solid organ transplantation from hepatitis C virus nucleic acid test-positive donors to hepatitis C virus-uninfected recipients: Results from the HCV-TARGET studyWesam Aleyadeh, Elizabeth C Verna, Hany Elbeshbeshy, et al.
Transplantation|February 26, 2015
Telaprevir- and Boceprevir-based Triple Therapy for Hepatitis C in Liver Transplant Recipients With Advanced Recurrent Disease: A Multicenter StudyElizabeth C Verna, Varun Saxena, James R Burton, et al.
Pageof 23